Registro:
Documento: |
Artículo
|
Título: | Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma |
Autor: | Vase, M.; Ludvigsen, M.; Bendix, K.; Dutoit, S.H.; Hjortebjerg, R.; Petruskevicius, I.; Møller, M.B.; Pedersen, G.; Denton, P.W.; Honoré, B.; Rabinovich, G.A.; Larsen, C.S.; D'Amore, F. |
Filiación: | Department of Hematology, Aarhus University Hospital, Tage Hansensgade 2, Aarhus C, DK-8000, Denmark Department of Clinical Medicine, Aarhus University, Denmark Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark Department of Pathology, Odense University Hospital, Odense, Denmark Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark Department of Infectious Diseases, Danish HIV Cohort, Aarhus University Hospital, Aarhus, Denmark Department of Biomedicine, Aarhus University, Aarhus, Denmark, Denmark Laboratorio de Inmunopatologiá, Instituto de Biologiá y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
|
Palabras clave: | CD30 antigen; CD68 antigen; CD8 antigen; galectin 1; granzyme B; galectin 1; tumor marker; CD4 lymphocyte count; clinical feature; disease course; human; Human immunodeficiency virus infection; immunohistochemistry; Letter; lymphoma; predictive value; priority journal; protein blood level; protein expression; tissue microarray; tumor microenvironment; virus load; blood; complication; Human immunodeficiency virus infection; lymphoma; pathology; predictive value; prognosis; Biomarkers, Tumor; Galectin 1; HIV Infections; Humans; Lymphoma; Predictive Value of Tests; Prognosis |
Año: | 2017
|
Volumen: | 31
|
Número: | 16
|
Página de inicio: | 2311
|
Página de fin: | 2313
|
DOI: |
http://dx.doi.org/10.1097/QAD.0000000000001622 |
Título revista: | AIDS
|
Título revista abreviado: | AIDS
|
ISSN: | 02699370
|
CODEN: | AIDSE
|
CAS: | galectin 1, 258495-34-0; granzyme B; Biomarkers, Tumor; Galectin 1
|
Registro: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02699370_v31_n16_p2311_Vase |
Referencias:
- Ouellet, M., Mercier, S., Pelletier, I., Bounou, S., Roy, J., Hirabayashi, J., Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells (2005) J Immunol, 174, pp. 4120-4126
- Mercier, S., St-Pierre, C., Pelletier, I., Ouellet, M., Tremblay, M.J., Sato, S., Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption (2008) Virology, 371, pp. 121-129
- St-Pierre, C., Manya, H., Ouellet, M., Clark, G.F., Endo, T., Tremblay, M.J., Sato, S., Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4 (2011) J Virol, 85, pp. 11742-11751
- Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci USA, 104, pp. 13134-13139
- Cedeno-Laurent, F., Watanabe, R., Teague, J.E., Kupper, T.S., Clark, R.A., Dimitroff, C.J., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood, 119, pp. 3534-3538
- Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
- Kamper, P., Ludvigsen, M., Bendix, K., Hamilton-Dutoit, S., Rabinovich, G.A., Moller, M.B., Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma (2011) Blood, 117, pp. 6638-6649
- Ouyang, J., Plütschow, A., Pogge Von Strandmann, E., Reiners, K.S., Ponader, S., Rabinovich, G.A., Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma (2013) Blood, 121, pp. 3431-3433
- Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
- Ouyang, J., Juszczynski, P., Rodig, S.J., Green, M.R., O'Donnell, E., Currie, T., Viral induction and targeted inhibition of galectin-1 in EBVR posttransplant lymphoproliferative disorders (2011) Blood, 117, pp. 4315-4322
- Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Méndez-Huergo, S.P., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res, 73, pp. 1107-1117
- Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, 73, pp. 86-96
- Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Méndez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Glycosylationdependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
- Vase, M., Ludvigsen, M., Bendix, K., Hamilton-Dutoit, S., Mller, M.B., Pedersen, C., Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development (2016) AIDS, 30, pp. 1889-1898
- Petruskevicius, I., Ludvigsen, M., Hjortebjerg, R., Sørensen, B.S., Kamper, P., Vase, M., Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation (2016) Bone Marrow Transplant, 51, pp. 1387-1390
- Rabkin, C.S., Engels, E.A., Landgren, O., Schuurman, R., Camargo, M.C., Pfeiffer, R., Goedert, J.J., Circulating cytokine levels, Epstein-Barr viremia and risk of acquired immunodeficiency syndromerelated non-Hodgkin lymphoma (2011) Am J Hematol, 86, pp. 875-878
- Breen, E.C., Hussain, S.K., Magpantay, L., Jacobson, L.P., Detels, R., Rabkin, C.S., B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma (2011) Cancer Epidemiol Biomarkers Prev, 20, pp. 1303-1314
- Hussain, S.K., Hessol, N.A., Levine, A.M., Breen, E.C., Anastos, K., Cohen, M., Serum biomarkers of immune activation and subsequent risk of non-Hodgkin B-cell lymphoma among HIV-infected women (2013) Cancer Epidemiol Biomark Prev, 22, pp. 2084-2093
- Toscano, M.A., Campagna, L., Molinero, L.L., Cerliani, J.P., Croci, D.O., Ilarregui, J.M., Nuclear factor (NF)-kB controls expression of the immunoregulatory glycan-binding protein galectin-1 (2011) Mol Immunol, 48, pp. 1940-1949
- Rodig, S.J., Ouyang, J., Juszczynski, P., Currie, T., Law, K., Neuberg, D.S., AP1-dependent galectin-1 expression delineates classical Hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features (2008) Clin Cancer Res, 14, pp. 3338-3344
- Liapis, K., Clear, A., Owen, A., Coutinho, R., Greaves, P., Lee, A.M., The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies (2013) Blood, 122, pp. 424-433
- Chao, C., Silverberg, M.J., Xu, L., Chen, L.H., Castor, B., Martnez-Maza, O., A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection (2015) Clin Cancer Res, 21, pp. 1429-1437
- Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., Toscano, M.A., Bianco, G.A., Isturiz, M.A., Rabinovich, G.A., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J Immunol, 178, pp. 436-445
- Riihijärvi, S., Fiskvik, I., Taskinen, M., Vajavaara, H., Tikkala, M., Yri, O., Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: A correlative study from a Nordic phase II trial (2015) Haematologica, 100, pp. 238-245
Citas:
---------- APA ----------
Vase, M., Ludvigsen, M., Bendix, K., Dutoit, S.H., Hjortebjerg, R., Petruskevicius, I., Møller, M.B.,..., D'Amore, F.
(2017)
. Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma. AIDS, 31(16), 2311-2313.
http://dx.doi.org/10.1097/QAD.0000000000001622---------- CHICAGO ----------
Vase, M., Ludvigsen, M., Bendix, K., Dutoit, S.H., Hjortebjerg, R., Petruskevicius, I., et al.
"Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma"
. AIDS 31, no. 16
(2017) : 2311-2313.
http://dx.doi.org/10.1097/QAD.0000000000001622---------- MLA ----------
Vase, M., Ludvigsen, M., Bendix, K., Dutoit, S.H., Hjortebjerg, R., Petruskevicius, I., et al.
"Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma"
. AIDS, vol. 31, no. 16, 2017, pp. 2311-2313.
http://dx.doi.org/10.1097/QAD.0000000000001622---------- VANCOUVER ----------
Vase, M., Ludvigsen, M., Bendix, K., Dutoit, S.H., Hjortebjerg, R., Petruskevicius, I., et al. Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma. AIDS. 2017;31(16):2311-2313.
http://dx.doi.org/10.1097/QAD.0000000000001622